Home > Publications database > Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial. > print

001     304294
005     20250904114814.0
024 7 _ |a 10.21037/hbsn-2025-316
|2 doi
024 7 _ |a pmid:40893741
|2 pmid
024 7 _ |a pmc:PMC12393116
|2 pmc
024 7 _ |a 2304-3881
|2 ISSN
024 7 _ |a 2304-389X
|2 ISSN
037 _ _ |a DKFZ-2025-01830
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Olkus, Alexander
|0 P:(DE-He78)0c6ebc2a9679701245512d27e35c5ac5
|b 0
|e First author
|u dkfz
245 _ _ |a Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial.
260 _ _ |a Hong Kong
|c 2025
|b AME Publishing Co.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756967976_27123
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D500#LA:D500#
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Immunotherapy
|2 Other
650 _ 7 |a biliary tract cancer (BTC)
|2 Other
650 _ 7 |a long-term survival
|2 Other
700 1 _ |a Dill, Michael
|0 P:(DE-He78)54a6641a6c26ddc49cc754740e90b438
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.21037/hbsn-2025-316
|g Vol. 14, no. 4, p. 676 - 679
|0 PERI:(DE-600)2812398-0
|n 4
|p 676 - 679
|t Hepatobiliary surgery and nutrition
|v 14
|y 2025
|x 2304-3881
909 C O |o oai:inrepo02.dkfz.de:304294
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)0c6ebc2a9679701245512d27e35c5ac5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)54a6641a6c26ddc49cc754740e90b438
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HEPATOBIL SURG NUTR : 2022
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-30
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HEPATOBIL SURG NUTR : 2022
|d 2024-12-30
920 2 _ |0 I:(DE-He78)D500-20160331
|k D500
|l NWG Experimentelle Hepatologie, Entzündung und Krebs
|x 0
920 1 _ |0 I:(DE-He78)D500-20160331
|k D500
|l NWG Experimentelle Hepatologie, Entzündung und Krebs
|x 0
920 0 _ |0 I:(DE-He78)D500-20160331
|k D500
|l NWG Experimentelle Hepatologie, Entzündung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D500-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21